ICM
BBBY

Invenomic Capital Management’s Bed Bath & Beyond BBBY Stock Holding History

Invenomic Capital Management’s Portfolio BBBY Stock Details BBBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-176,033
Closed -$4M – 151
2022
Q2 		$4M Buy
+176,033
New +$5.29M 0.28% 90
2020
Q2 		– Sell
-25,392
Closed -$104K – 159
2020
Q1 		$104K Buy
+25,392
New +$138K 0.09% 141

Other funds holding BBBY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Invenomic Capital Management's BBBY Position: Q3 2022 in Review

Invenomic Capital Management sold out of Bed Bath & Beyond (BBBY) in Q3 2022, closing a stake of 176,033 shares — an estimated $4M sold.

Invenomic Capital Management first reported a position in BBBY in Q1 2020 and held it in 2 quarters. The position peaked at $4M in Q2 2022. 208 funds tracked by Wall St. Rank hold BBBY as of Q3 2022.

  • Invenomic Capital Management reported no remaining Bed Bath & Beyond position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 176,033 Bed Bath & Beyond shares in Q3 2022, an estimated $4M.
  • Invenomic Capital Management first reported a position in Bed Bath & Beyond in Q1 2020 and held it in 2 quarters.
  • Invenomic Capital Management's Bed Bath & Beyond position peaked at $4M in Q2 2022.
  • 208 funds tracked by Wall St. Rank held Bed Bath & Beyond as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.